Jin Jin Selected Research

11(13)-dehydroivaxillin

1/2017

Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Jin Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 09/2006
12	Inflammation (Inflammations) 02/2022 - 05/2013
11	Infections 05/2021 - 09/2002
11	Pain (Aches) 01/2020 - 08/2005
10	Osteoarthritis 01/2020 - 09/2002
7	Body Weight (Weight, Body) 12/2017 - 01/2012
6	Rheumatoid Arthritis 01/2021 - 09/2002
6	Breast Neoplasms (Breast Cancer) 02/2019 - 01/2014
5	Joint Diseases (Joint Disease) 06/2021 - 06/2008
5	Arthritis (Polyarthritis) 01/2017 - 08/2005
4	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2017
4	Colitis 01/2022 - 01/2015
4	Oncogenic osteomalacia 01/2022 - 11/2013
4	Osteonecrosis (Kienbock's Disease) 01/2021 - 01/2013
4	Virus Diseases (Viral Diseases) 01/2019 - 01/2011
3	Fibrosis (Cirrhosis) 02/2022 - 06/2019
3	Asthma (Bronchial Asthma) 01/2022 - 01/2018
3	Congenital Abnormalities (Deformity) 06/2021 - 08/2005
3	Leukemia 01/2021 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2018
3	Anemia 04/2019 - 03/2012
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 02/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 03/2016
3	Adenocarcinoma 01/2019 - 07/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2018 - 09/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2013
3	Wounds and Injuries (Trauma) 05/2011 - 05/2008
2	Adenocarcinoma of Lung 03/2022 - 01/2021
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2022
2	Genetic Risk Score 01/2022 - 09/2021
2	Hypersensitivity (Allergy) 11/2021 - 02/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2021 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 07/2013
2	Pancreatitis 11/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2018
2	Intervertebral Disc Displacement (Herniated Disc) 01/2020 - 01/2020
2	Venous Thromboembolism 01/2020 - 09/2012
2	Necrosis 11/2019 - 05/2008
2	Idiopathic Pulmonary Fibrosis 06/2019 - 01/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 01/2019
2	Disease Progression 01/2019 - 09/2014

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2008
10	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
6	Fibroblast Growth Factor-23IBA 01/2022 - 11/2013
5	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 02/2010
5	CytokinesIBA 01/2021 - 01/2015
5	Phosphorus (Red Phosphorus)IBA 01/2020 - 09/2012
5	AntigensIBA 08/2019 - 02/2010
5	Bevacizumab (Avastin)FDA Link 08/2016 - 07/2013
4	Biological ProductsIBA 02/2022 - 01/2017
4	fibrin fragment D (D-dimer)IBA 05/2021 - 11/2018
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 01/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2015 - 09/2002
3	Monoclonal AntibodiesIBA 01/2022 - 10/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
3	UbiquitinIBA 01/2022 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 09/2021 - 01/2008
3	SteroidsIBA 01/2021 - 01/2013
3	parecoxibIBA 01/2020 - 01/2018
3	InflammasomesIBA 01/2020 - 01/2020
3	Therapeutic UsesIBA 11/2018 - 05/2012
3	Ado-Trastuzumab EmtansineIBA 01/2018 - 12/2017
2	Interleukin-10 (Interleukin 10)IBA 11/2022 - 01/2017
2	Capsules (Microcapsules)IBA 06/2022 - 01/2017
2	astegolimabIBA 01/2022 - 10/2021
2	Chemokine ReceptorsIBA 01/2022 - 01/2020
2	AlbuminsIBA 01/2022 - 04/2019
2	Ligases (Synthetase)IBA 09/2021 - 01/2018
2	Fibrinogen (Factor I)FDA Link 05/2021 - 11/2018
2	oxidized low density lipoproteinIBA 01/2021 - 03/2010
2	IntegrinsIBA 01/2021 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 09/2007
2	Glucose (Dextrose)FDA LinkGeneric 07/2020 - 01/2015
2	Chimeric Antigen ReceptorsIBA 01/2020 - 10/2019
2	lipoxin A4IBA 01/2020 - 01/2020
2	Beclin-1IBA 01/2020 - 01/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2019 - 04/2019
2	Alkaline PhosphataseIBA 03/2019 - 07/2017
2	Dihydrotachysterol (AT 10)IBA 01/2019 - 12/2014
2	RamucirumabIBA 01/2019 - 12/2018
2	Propofol (Diprivan)FDA LinkGeneric 01/2019 - 01/2016
2	Dexmedetomidine FDA Link 01/2019 - 10/2017

Therapy/Procedure

18	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021 - 09/2002
12	Therapeutics 11/2021 - 08/2014
7	Hip Replacement Arthroplasty (Total Hip Replacement) 06/2021 - 02/2005
6	Arthroplasty 01/2018 - 08/2005
5	Immunotherapy 11/2021 - 01/2017
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
3	Analgesia 11/2018 - 01/2018
3	Replacement Arthroplasty 02/2016 - 03/2011
3	Aftercare (After-Treatment) 06/2015 - 03/2010
3	Debridement 05/2011 - 09/2002
3	Prostheses and Implants (Prosthesis) 06/2009 - 09/2002
2	Ligation 01/2022 - 01/2022
2	Hysterectomy 08/2019 - 11/2018